Lupin Share Price

ABOUT Lupin

• Industry Biotechnology & Drugs
• ISIN INE326A01037
• BSE Code 500257
• NSE Code LUPIN

Lupin Limited is a global pharmaceutical company, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. It operates in India and the United States across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. It has a presence in the Cardiovascular, Diabetology, Asthama, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives and Nonsteroidal Anti Inflammatory Drug therapy segments and operates in the Anti-TB and Cephalosporins segments. Its generic formulations include Filgrastim, Pegfilgrastim, Etanercept and Albuterol. Its diabetes brands include Gibtulio, Ajaduo, Gibtulio Met, ONDERO and ONDERO MET. Its other brands include AntaGolin, RyChol and others. Its Huminsulin range of products includes Insulin Human.

MANAGEMENT

• Vinita Gupta Chief Executive Officer, Executive Director
• Ramesh Swaminathan Executive Director, Global Chief Financial Officer, Chief Risk Officer and Head of API Plus SBU
• Rajendra Chunodkar President - Manufacturing Operations
• Fabrice Egros President - Corporate Development and Growth Markets
• Spiro Gavaris President - U.S. Generics
• Claus Jepsen President - Global Specialty
• Cyrus Karkaria President - Biotechnology
• Sofia Mumtaz President - Legal, Canada and APAC
• Rajeev Sibal President - India Region Formulations
• Abdelaziz Toumi Chief Executive Officer - Lupin Manufacturing Solutions